TNFα induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2

Atherosclerosis

Volumn 159, Issue 1, 2001, Pages 93-101

  Goetze, Stephan ^a   Kintscher, Ulrich ^a   Kaneshiro, Kristina ^b   Meehan, Woerner P ^b   Collins, Alan ^b   Fleck, Eckart ^a   Hsueh, Willa A ^b   Law, Ronald E ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extracellular signal regulated kinase 1 2; TNF ; Transcription factors; Vascular lesions

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; FRUCTOSE; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR ETS 1; TUMOR NECROSIS FACTOR ALPHA; DNA BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, MOUSE; EGR1 PROTEIN, RAT; ENZYME INHIBITOR; ETS1 PROTEIN, MOUSE; ETS1 PROTEIN, RAT; FLAVONOID; IMMEDIATE EARLY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS;

ANIMAL CELL; ANIMAL TISSUE; AORTA; AORTA BALLOON; ARTICLE; ATHEROSCLEROSIS; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; INHIBITION KINETICS; INJURY; INTIMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; STIMULATION; VASCULAR LESION; VASCULAR SMOOTH MUSCLE; ANIMAL; ARTERIOSCLEROSIS; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CELLS, CULTURED; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME INHIBITORS; FLAVONOIDS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034740115     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00497-X     Document Type: Article

References (55)

1. Migration of smooth muscle and endothelial cells. Critical events in restenosis
2. The pathogenesis of atherosclerosis: A perspective for the 1990s
3. Perspectives series: Cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis
4. Signalling mechanisms in the regulation of vascular cell migration
5. TNF-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta
6. Production of tumor necrosis factor and interleukin-1 by macrophages from human atherosclerotic plaques
7. Expression of tumor necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy
8. TNFα-induced migration of vascular smooth muscle cells is MAPK-dependent
9. TNFα-induced regulation and signaling in macrophages
10. Activation of p42 MAPK/ERK following engagement of TNF receptor CD120a(p55) in mouse macrophages
11. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation
12. Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE
13. Troglitazone inhibits AII-induced ERK 1/2 nuclear translocation and activation in vascular smooth muscle cells
14. Egr-1 mediates extracellular matrix-driven transcription of membrane type I matrix metalloproteinase in endothelium
15. Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro
16. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes
17. The zink finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage
18. Localization of fos and jun proteins in rat aortic smooth muscle cells after vascular injury
19. Angiotensin II type I receptor blockade inhibits the expression of immediate early genes and fibronectin in rat injured arteries
20. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery
21. Hyperexpression and activation of extracellular signal-regulated kinases (ERK1/2) in atherosclerotic lesions of cholesterol-fed rabbits
22. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis
23. Analysis of synergistic stimulation of mouse macrophage proliferation by macrophage colony-stimulating factor and tumor necrosis factor alpha
24. TNF-alpha potently enhances in vitro macrophage production from primitive hematopoietic progenitor cells in combination with stem cell factor and interleukin-7: Novel stimulatory role of the p55 TNF receptor
25. Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation
26. The smooth muscle cell in culture
27. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
28. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet
29. Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2
30. Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal-transduction of basic fibroblast growth in endothelial cells during angiogenesis
31. Cytokines regulate vascular functions related to stability of the atheroscerotic plaque
32. Human monocyte/macrophages release TNFalpha in response to Ox-LDL
33. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
34. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice
35. Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells
36. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
37. The role of TNF in cardiovascular disease
38. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques. Evidence for activation by proinflammatory mediators
39. Mitogen-activated protein kinase activation is involved in platelet- derived growth factor-directed migration by vascular smooth muscle cells
40. Regulation of matrix metalloproteinase expression in tumor invasion
41. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes
42. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury
43. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation
44. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent
45. Oligodeoxynucleotides directed to early growth response gene-1 mRNA inhibit DNA synthesis in the smooth muscle cell
46. Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells
47. Characterization of a Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter
48. Regulation of the human TNF promoter by the transcription factor Ets
49. Arachidonic acid activates Jun N-terminal kinase in vascular smooth muscle cells
50. Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells
51. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-jun N-terminal kinase/p38 mitogen-activated protein kinase pathways
52. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis
53. Activation of nor only ERK but also JNK are necessary for balloon injury-induced neointima formation
54. Direct in vivo evidence for TNFalpha signaling in neointimal hyperplasia
55. Blockade of the MAPK pathway suppresses growth of colon tumors in vivo